Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
DF-1001 by Bristol-Myers Squibb for Colorectal Cancer: Likelihood of Approval
DF-1001 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...
Data Insights
DF-1001 by Bristol-Myers Squibb for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
DF-1001 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Human Epidermal Growth Factor Receptor 2...